Entries |
Document | Title | Date |
20080213396 | Copper Lowering Treatment Of Cardiac Disease - The present invention relates generally to the field of prophylaxis and therapy for cardiac fibrosis. In particular, the present invention is related to agents that can bind or complex copper, and to the use of these agents in the prevention and treatment of cardiac damage caused by chemotherapeutic and pharmaceutical agents. | 09-04-2008 |
20080213397 | NUTRIENT COMPOSITIONS AND METHODS FOR ENHANCED EFFECTIVENESS OF THE IMMUNE SYSTEM - The invention provides a nutrient composition for augmenting immune strength or physiological detoxification. The nutrient composition consists of an optimal combination of an effective amount of at least one vitamin antioxidant, at least one mineral antioxidant and a highly saturable amount of at least three high potency antioxidants. The at least one vitamin antioxidant can be vitamin C, bioflavonoid complex, vitamin E, vitamin B6 or beta-carotene and the at least one mineral antioxidant can be zinc or selenium. The at least three high potency antioxidants can be alpha lipoic acid, acetyl L-carnitine, N-acetyl-cysteine, co-enzyme Q10 or glutathione. Also provided is a nutrient composition for augmenting immune strength or physiological detoxification that consists of an optimal combination of an effective amount of at least three vitamin antioxidants, at least two mineral antioxidants and a highly saturable amount of at least three high potency antioxidants. Further provided is a method of stimulating immune system function or a method of augmenting a therapeutic treatment of a disease. The method consists of administering to an individual a nutrient composition of the invention one or more times a day over a period of about 5-7 weeks, the immune system function being stimulated to result in an increase of CD4+ cells of at least about 15% compared to pre-administration levels. A method of stimulating a physiological detoxification function of an individual or a method of augmenting a therapeutic treatment of a disease is also provided. The method consists of administering to an individual a nutrient composition of the invention one or more times a day over a period of about 5-7 weeks, the physiological detoxification function being stimulated to result in a decrease of one or more free radical markers by about 20% compared to pre-administration levels. | 09-04-2008 |
20080233206 | COMPOSITIONS AND METHODS FOR ANTI-INFLAMMATORY TREATMENTS - The present invention relates to an improved method for treating a wide range of inflammatory disorders by administering a tetracycline compound together with an effective inhibitor of tetracycline absorption, such as polyvalent metals. Pharmaceutical compositions used in that method are also taught. | 09-25-2008 |
20080241271 | Foaming anti-adhesion composition - A method to treat nasal tissue reduces the ability of a virus to infect a human being. The method comprises the steps of providing a liquid composition comprising water, a humectant, a foam builder, 0.01% to 9% by weight of a surfactant, and a minor effective quantity of thickener to produce a coating on the nasal tissue after the liquid composition is applied to the nasal tissue as a foam; applying the liquid composition to the nasal tissue as a foam; and, allowing bubbles in the foam to dissipate so that a coating forms on the nasal tissue. | 10-02-2008 |
20080254143 | COMPOSITION FOR IMPROVING IMMUNE SYSTEM HEALTH - A composition and method for enhancing the immune system of an individual is provided. The present invention enhances the functioning of the immune system through increasing the production of certain cytokines, inhibiting viral adhesion and interfering in the viral replication process. The severity and duration of infections resulting from the common cold and associated viral infections are also reduced through the oral administration of the composition of the present invention. The composition of the present invention comprises at least an effective amount of an extract of wolfberry ( | 10-16-2008 |
20080254144 | Beverage health formulations - Dietary supplement formulations are described that provide benefits of soluble fiber accompanied by excellent taste with many different health benefit combinations. | 10-16-2008 |
20080260859 | Composition Containing Omega-3 Fatty Acids and Omega-6 Fatty Acids - A composition comprises at least an omega-3 fatty acid, at least an omega-6 fatty acid, and zinc. The composition is advantageously administered to a subject suffering from a condition of dry eye. In certain embodiment, the amount of omega-3 fatty acid is much higher than that of the omega-6 fatty acid. | 10-23-2008 |
20080260860 | Method for the Acaricidal Finishing of Textile Materials - The use is described of zinc pyrithione for finishing woven and non-woven textiles to render them resistant against colonization by house dust mites. Zinc pyrithione is used alone or in combination with other actives with or without other textile chemicals. The formulations comprising zinc pyrithione are applied to the textiles using the standard processes of textile finishing, such that there is a concentration of preferably 1000 to 6000 ppm of zinc pyrithione on the textile. This gives on uncoated sheetlike textiles a very distinct reduction in the mite population in testing; ideal finishes even eliminate the mite population completely. | 10-23-2008 |
20080268066 | Synergistic Formulation for Preventing and/or Treating Diabetes - The present invention discloses a composition preparation for preventing and treating diabetes, which mainly contains oral hypoglycemic agents, Vitamin E, chromic pyridine formate, selenium, lutein, folic acid, Vitamin C, alpha_lipoic acid, lycopene, nicotinamide, coenzyme Q10, and vitamin complexes and mineral. The medicament of the invention can decrease oxidative stress in vivo, promote body immunity, repair the critical organs in vivo such as pancreas, by supplying the mineral, vitamins and other substances which are insufficient in the patient suffering from diabetes, to prevent and treat diabetes. | 10-30-2008 |
20080268067 | Methods and Compositions for Treating Thalamocortical Dysrhythmia - This invention relates to methods of inhibiting a Ca | 10-30-2008 |
20090004291 | COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND DEMENTIA - The present invention relates to a method of treating, preventing, or delaying the onset of Alzheimer's disease and/or dementia in mammals. More particularly, the invention relates to method of administration of compositions containing defined chemical species useful for treating, preventing, or delaying the onset of Alzheimer's disease and/or dementia in mammals. In some embodiments, a composition used in connection with such methods comprises one or more of 1) thyroid hormone and 2) cyclo(His-Pro) and a zinc salt. Such compositions may also be used to treat metabolic syndrome and cerebrovascular diseases. | 01-01-2009 |
20090017136 | Formulation to prevent and treat fibromyalgia, depression and other muscle and nervous system disorders - The formulation provides for the treatment and prevention of fibromyalgia, depression and other muscle and nervous system disorders. The formulation combines Coenzyme Q10, vitamin B1, 5-Hydroxytryptophan, magnesium, Vitamin D, Vitamin C, Selenium and Zinc. Each component has an effect on its own combined with a synergistic effect with other components. | 01-15-2009 |
20090035390 | Compositions containing zinc salts for coating medical articles - The present invention relates to methods and compositions which employ low concentrations of combinations of zinc salts and antimicrobial agents in coatings for medical articles. The coatings have an anti-irritant effect and inhibit transmission of infectious disease. | 02-05-2009 |
20090035391 | Nasal Irrigation Solutions And Methods Of Using Same - A nasal irrigation solution comprising is disclosed comprising water and hydrastine extracted from one or more plants. Another solution comprises water and berberine extracted from one or more plants. These solutions are provided from an extract of goldenseal plant. Solutions are also disclosed having canadine, canadaline, and hydrastidine, all extracted from the goldenseal plant. More general solutions are disclosed including alkaloids extracted from one or more plants. The alkaloids are selected from one or more of the group consisting of: berberine, oxyberberine, berbamine, palmatine, magnoflorine, phellodendrine, jateorrhizine, candicine, menisperine, coptisine, worenine, columbamine, epiberberine, hydrastine, canadine, canadaline, hydrastidine, oxycyanthine, berberrubine, and isotetrandine. Alkaloids are provided from plant from the group consisting of: Oregon grape root, yellow root, phellodendron bark, coptis rhizome, barberry root, and Indian barberry root bark. Other constituents may include extract of grapefruit seed, vegetable glycerine, salt, and water soluble zinc. A method for using these solutions is disclosed which includes flowing the solution through desired portions of nasal cavities. | 02-05-2009 |
20090068285 | Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate - The present invention provides novel biomaterials comprising one or more of Mg, Zn and F ions in a carbonate-containing biphasic calcium phosphate (BCP) system. The biomaterial may contain Mg, Zn, F, Mg and Zn, Mg and F, Zn and F, or Mg, Zn and F. The biomaterial may be substantially similar in composition to bone mineral (a carbonate apatite). The biomaterial may feature slow release of Mg, Zn, F, Ca, and P ions. The biphasic calcium phosphate, BCP, may be a mixture of unsubstituted hydroxyapatite (HA) and unsubstituted .-TCP, Ca | 03-12-2009 |
20090074882 | INSULIN COMPOSITIONS AND METHOD OF MAKING A COMPOSITION - The invention is related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. The insulin is an acylated insulin and may be mixed with a further insulin analogue such as the rapid acting insulin Asp B28 human insulin. | 03-19-2009 |
20090081313 | Biodegradable Magnesium Alloys and Uses Thereof - Novel magnesium-based compositions-of-matter which can be used for manufacturing implantable medical devices such as orthopedic implants are disclosed. The compositions-of-matter can be used for constructing monolithic, porous and/or multilayered structures which are characterized by biocompatibility, mechanical properties and degradation rate that are highly suitable for medical applications. Articles, such as medical devices, made of these magnesium-based compositions-of-matter and processes of preparing these magnesium-based compositions-of-matter are also disclosed. | 03-26-2009 |
20090087497 | Compositions and methods for treating symptoms of aging - Compositions and methods are provided that are based on a discovery that a combination of three compounds, doxycycline, selenium, and zinc, retards physiological age-related changes (for example cardiac aging and the decline in exercise capacity) and can also prolong survival. | 04-02-2009 |
20090104283 | METHOD FOR REDUCING THE SEVERITY OF NEUROLOGICAL DISORDERS - The present invention relates to the use of
| 04-23-2009 |
20090123563 | Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand - Novel preparations comprising branched ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The preparations have a prolonged action designed for flexible injection regimes. | 05-14-2009 |
20090136591 | METALLOTHIONEIN AS AN EARLY BIOMARKER FOR DEATH SECONDARY TO SEPTIC SHOCK AND AS A NOVEL THERAPEUTIC TARGET FOR SEPTIC SHOCK - A set of signature genes that predict the severity of septic shock, as well as methods of diagnosing and treating septic shock. The genes and methods are particularly useful for the identification of individuals who are at a high risk of death from septic shock. | 05-28-2009 |
20090136592 | Vitamin preparation - Two-phase preparation for temporally gradual administration comprising
| 05-28-2009 |
20090155382 | Methods and Compositions for Heavy Metal Detoxification - Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity. | 06-18-2009 |
20090169643 | Composition for Enhancing Immune Function - The present invention disclosed a composition for enhancing immune function comprising, as active ingredients, zinc and a saccharide having 3-O-α-D-glucopyranosyl-D-glucose as a structural unit. The composition for enhancing immune function according to the present invention exhibits a remarkably superior immunoenhancing effect to that achieved by the independent use of zinc and a saccharide having 3-O-α-D-glucopyranosyl-D-glucose as a structural unit. | 07-02-2009 |
20090202658 | Versatile antimicrobial agent and uses thereof - The present disclosure relates, according to some embodiments, to antimicrobial agents comprising nitric acid, tetraethylorthosilicate, tetraethyl phosphate, zinc nitrate, and gallium nitrate. Antimicrobial agents may also include borane-tert-butylamine. Antimicrobial agents restrict and/or prevent the growth of at least one bacteria and/or at least one fungus. Bacteria may include, for example, Actinomyetes (e.g., | 08-13-2009 |
20090226538 | ANTICANCER OR ANTIVIRAL COMPOSITION - Disclosed is an anticancer or an antiviral composition comprising therapeutically effective amounts of citric acid and or zinc and L-arginine along with a pharmaceutically acceptable carrier. The anticancer composition of the present invention has a strong anticancer effect while not having harmful side effects. The antiviral compositions of the present invention is useful for treatment of diseases caused by viral infections. | 09-10-2009 |
20090280190 | ANTI-ANGIOGENIC PEPTIDES FROM THE N-TERMINUS OF ENDOSTATIN - Provided herein are anti-angiogenic comprising the N-terminal end of endostatin, nucleic acids encoding the same, pharmaceutical preparations comprising an effective amount of the peptide and nucleic acids and use of the pharmaceuticals in treating or preventing diseases or conditions associated with undesirable angiogenesis. | 11-12-2009 |
20090291148 | Depilatory Kit Resulting in Reduced Odor and Irritation - A depilatory kit may comprise a depilatory composition comprising a sulfur-containing depilatory agent and a finishing composition comprising a metal oxide selected from the group consisting of zinc oxide, aluminum oxide, and magnesium oxide. The depilatory composition may further comprise a lactone such as 1,15-cyclopentadecanolide. Methods for using the depilatory kits are also disclosed herein. | 11-26-2009 |
20090297625 | AGENT FOR TREATING EYE DISEASES - The invention relates to chemical and pharmaceutical industry, in particular to developing ophthalmological agents having a wide spectrum of action based on vegetable components, vitamins, and trace elements. The agent for treating eye diseases comprises lyophilized blueberries, dihydroquercetin, beta-carotene, selexen, lutein, vitamins B | 12-03-2009 |
20090304814 | FIBRILLATION RESISTANT PROTEINS - Protection of proteins against fibrillation may be afforded by introduction of certain histidine substitutions into the protein, such that a pair of histidines are present with sufficient spacing as to allow the histidines to coordinate with zinc. In the case of insulin, introduction of histidine residue substitutions at residues A4 and A8 together or a histidine residue substitution at residue B1, provides increased resistance to fibrillation while maintaining at least a majority of the activity of the insulin analogue. Introduction of a histidine residue substitution at residue A8 restores at least a portion of fibrillation resistance that may have been harmed by substitutions present on the B-chain such as those present in fast-acting insulins. Proteins protected by such histidine substitutions may be used to provide a pharmaceutical composition. A method of treating a patient includes administering a physiologically effective amount of the pharmaceutical composition to the patient. | 12-10-2009 |
20090317486 | WEEKLY FLOATER POOL SANITIZER - A composition for the treatment of a liquid, particularly a body of water, such as a swimming pool, spa, or the like. The composition includes calcium hypochlorite, a water soluble zinc salt for controlling algae, and sodium aluminate as an agglomerating agent that may safely be combined with said calcium hypochlorite and said zinc salt. A floating chemical dispenser for containing and dispensing chemicals to treat a body of water. The dispenser includes an upper end float, a container adapted to contain chemicals, the container removably joined with the upper end float, and a free end float joined with the container. The free end float is configured so that a central axis of the container and upper end float is not substantially orthogonal to a surface of the water. | 12-24-2009 |
20090317487 | KITS FOR PREVENTION AND TREATMENT OF RHINITIS - Kits providing a combination of one or more pharmaceutical information comprising one or more agent(s) for the treatment or alleviation of symptoms commonly associated with a cold and an immunonutritional composition comprising immunonutritional agent and methods of using these kits are described. The kits provide both the pharmaceutical agent(s) and the immunonutritional agent in a convenient form for administration. The kit typically includes instruction for coordinating the administration of the pharmaceutical formulation with the administration of the immunonutritional composition. The preferred immunonutritional agents are compounds that contain a pharmaceutically acceptable form of zinc, such as zinc acetate, zinc gluconate, zinc gluconate glycine, and zinc sulfate. Preferably the kit contains multiple dosage forms containing the immunonutritional composition. In the most preferred embodiment, the immunonutritional composition is in the form of a lozenge. Suitable pharmaceutical agents include but are not limited to antihistamines, decongestants, anticholinergics, antitussives, analgesics, mucolytics, expectorants, and combinations thereof. The pharmaceutical formulations may be in any suitable dosage form, including forms which provide controlled release of the pharmaceutical agent, including immediate, sustained, modified, delayed or pulsed release pharmacokinetic mechanism or a combination thereof. The combined treatment requires administration of both the pharmaceutical formulation(s) for the treatment of symptoms commonly associated with a cold and the administration of the immunonutritional composition, which supplies nutritional support for the patient's innate immune response to the presence of infectious organisms. | 12-24-2009 |
20090324740 | NOVEL NASAL SPRAY - Systems and methods are disclosed for treating a plurality of sinsousal conditions to be treated. These systems and methods include selecting a combination of at least two compounds that are capable of addressing a plurality of sinsousal conditions. At least one of the at least two compounds is selected from a group of anti fungals, antioxidants, and chelators. These systems and methods also include verifying that the compounds are biologically compatible and creating a combination compound using the selected compounds. | 12-31-2009 |
20100003345 | Synergistic antimicrobial mixtures - A broad spectrum antimicrobial composition comprising a mixture of an iodopropynyl compound in combination with a benzimidazole and a metal borate is disclosed. The composition can be used to protect industrial systems against microbial growth and, more particularly, to protect substrates such as paints, coatings, stucco, concrete, stone, cementaceous surfaces, wood, wood-plastic composites, caulking, sealants, textiles, leather, wood, preservatives, metal working fluids, drilling muds, clay slurries, glazes, optical brighteners, carpet backing, and pigments against microbial growth. The composition can be used as a preservative for aqueous products. | 01-07-2010 |
20100021561 | SELF-PRESERVED AQUEOUS PHARMACEUTICAL COMPOSITIONS - The use of borate/amino alcohol/zinc systems to enhance the antimicrobial activity of multi-dose pharmaceutical compositions is described. The compositions do not require a conventional anti-microbial preservative and therefore are referred to as being “self-preserved”. The compositions possess sufficient antimicrobial activity to satisfy the preservative efficacy requirements of the USP for aqueous ophthalmic compositions. | 01-28-2010 |
20100021562 | SELF PRESERVED AQUEOUS PHARMACEUTICAL COMPOSITIONS - The use of a borate/polyol and zinc system to enhance the antimicrobial activity of multi-dose pharmaceutical compositions is described. The compositions do not require a conventional anti-microbial preservative and therefore are referred to as being ‘self-preserved’. The compositions possess sufficient antimicrobial activity to satisfy the preservative efficacy requirements of the USP for aqueous ophthalmic compositions. | 01-28-2010 |
20100047366 | ARTICLES WITH ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY - The present invention relates to articles with antibacterial and antifungal activity, comprising zinc sulphide. The yarns, fibres, filaments and articles according to the present invention may be used especially in the manufacture of any product liable to be placed in contact with bacteria and/or fungi, for instance clothing, rugs, curtains, bedclothes and medical textile materials. The present invention also relates to the use of zinc sulphide for manufacturing yarns, fibres, filaments and/or articles with antibacterial and antifungal properties. | 02-25-2010 |
20100068300 | USE OF L-CARNITINE FOR THE PREPARATION OF A MEDICAMENT IN THE FORM OF EYE-DROPS FOR TREATING CORNEAL DISEASES - Use of L-carnitine or a pharmaceutically acceptable salt thereof, for the preparation of an opthalmic physiological supplement or medicament in the form of eye-drops, for the treatment of corneal oedema. | 03-18-2010 |
20100098779 | COMPOSITIONS AND METHODS FOR PROPHYLACTIC AND THERAPEUTIC SUPPLEMENTATION OF NUTRITION IN SUBJECTS - The present invention relates to compositions and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the composition provides a nutritional supplement with a beneficial increased supplementation of vitamin D and the method involves administering to an individual a composition comprising carotenoids, vitamin E, vitamin D, vitamin C, thiamine, riboflavin, niacin, folic acid, pyridoxine, biotin, pantothenic acid, cobalamin, magnesium, manganese, zinc, selenium, chromium, copper, alpha lipoic acid, and lutein. | 04-22-2010 |
20100173012 | METHODS FOR TREATING AN APPLE TREE INFECTED WITH VENTURIA INAEQUALIS - A method of treating an apple orchard to reduce infection of the apple orchard by | 07-08-2010 |
20100183740 | Potent Inhibitory Effect of Zinc in Combination with Sulforaphane on Cancer Cell Growth - This invention relates to compositions comprising zinc and sulforaphane which can be used in the treatment or prevention of cancer. The invention also relates to methods of treating or preventing cancer, including prostate cancer, which comprises the administration of zinc and sulforaphane to a patient in need thereof. | 07-22-2010 |
20100209536 | Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases - This invention provides methods of treating and preventing diseases or conditions of the immune system or infectious disease, involving administration of vitamin D and/or one or more antioxidants (e.g., vitamin E and/or zinc). | 08-19-2010 |
20100215768 | NUTRITIONAL SUPPLEMENT - A nutritional supplement includes elements having been shown to enhance DNA repair or reduce DNA damage by different molecular mechanisms while excluding other bioactive nutrient agents which compete with any of the elements known modes of action. The supplement includes a resveratrol, a carotenoid, a nicotinamide, a dimethylaminoethanol, a zinc source, and a quinic acid analog. The supplement is administered daily in dosages in excess of normal dietary levels. The supplement improves resistance to DNA damage, enhances DNA repair capacity in tissues including skin, and stimulates immune cellular function. This was accomplished by reducing metabolic competition between DNA repair bioactive components that was in turn paralleled by enhancement of thirst quenching properties in aqueous formulations. | 08-26-2010 |
20100227002 | ANTIOXIDANT COMPOSITIONS COMPRISING EXTRACTS OF MYRTLE AND ROSEMARY - The invention relates to a composition based on extracts of myrtle and rosemary which has been found to synergistically increase the protection of cells against pathophysiological conditions characterised and partly caused by overproduction of free radicals and to counteract the oxidative stress caused by excessive production of said free radicals, as well as for preventing and/or treating related pathologies, including apoptosis. | 09-09-2010 |
20100255119 | Mucositis Prevention Supplement and Treatment - The present invention provides for a nutritional composition comprising from 0.25 g to 25 g of glutamine, in neutral or salt form or precursor or derivative thereof; and from 0.1 g to 10 g of a phytochemical or a mixture thereof, wherein the phytochemical is an antioxidant. The nutritional composition is particularly useful in the treatment and/or prevention of mucositis. | 10-07-2010 |
20100266708 | INTRA-MAMMARY TEAT SEALANT FORMULATION AND METHOD OF USING SAME TO REDUCE OR ELIMINATE VISUAL DEFECTS IN AGED CHEESES - Described is an intra-mammary teat sealant and a corresponding method of forming a physical barrier in the teat canal of a non-human animal for prophylactic treatment of mammary disorders during the animal's dry period. The method includes the step of infusing a teat seal formulation including a metal salt in a glyceride-containing gel base into the teat canal of the animal. The method also prevents the formation of black spot defect in dairy products, especially cheddar cheese, made from the milk of animals so treated. | 10-21-2010 |
20100297260 | PESTICIDE COMPOSITIONS EXHIBITING ENHANCED ACTIVITY - Pest controlling compositions exhibiting enhanced pesticidal activity levels are disclosed. In one embodiment, a composition includes at least one pesticide, at least one transition metal salt and at least one proteinaceous material. In this embodiment, the composition exhibits enhanced pesticidal activity levels compared to a composition dissimilar only in not having the at least one transition metal salt and the at least one proteinaceous material. | 11-25-2010 |
20100316733 | Hyperbaric Oxygen Therapy and Treatment Method - A method of treating cancer concurrent with receiving chemotherapy treatments which may effectively ameliorate the anemic and toxic effects induced by chemotherapy includes prescribing at least three hyperbaric oxygen therapy treatments per week at a pressure of at least 1.5 ATA, the treatments lasting at least 30 minutes each, prescribing a diet including less than about 300 grams of carbohydrates a day, and prescribing nutritional supplements in accordance with a nutritional supplement regimen including elevated amounts of vitamin B-12, vitamin E, and zinc as compared to a reference daily intake. | 12-16-2010 |
20110052721 | INTRA-MAMMARY TEAT SEALANT FORMULATION AND METHOD OF USING SAME TO REDUCE OR ELIMINATE VISUAL DEFECTS IN AGED CHEESES - Described is an intra-mammary teat sealant and a corresponding method of forming a physical barrier in the teat canal of a non-human animal for prophylactic treatment of mammary disorders during the animal's dry period. The method includes the step of infusing a bismuth-free teat seal formulation into the teat canal of the animal. The method also prevents the formation of black spot defect in dairy products, especially cheddar cheese, made from the milk of animals so treated. | 03-03-2011 |
20110091576 | Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growrh factors of stem cells - A method for the treatment and prophylaxis of conditions of aging due oxidative stress and as growth factors of stem cells. Such conditions due to oxidative stress are associated with a decreased presence of one or more cell-specific carbonic anhydrase enzymes in the tissue of a subject. Such conditions include but are not limited to alzheimer's disease, parkinson's disease, multiple sclerosis, autism, lou gehrig's disease, huntington's disease, diabetes mellitus, amyloid diseases, atherosclerosis, arthritis, osteoporosis, cystic fibrosis. The method comprises administering to the patient a pharmaceutically effective, non-toxic amount of one or more compounds that increases the presence of one or more Carbonic Anhydrase Isozymes whose levels have been reduced in the subject. Such compound maybe the Cell Specific Carbonic Anhydrase Enzymes, a compound that when absorbed reacts or dissociates to form cell specific carbonic enzymes or a compound that when administered promotes the natural generation of the cell specific carbonic anhydrase enzymes within the subject. | 04-21-2011 |
20110123643 | COPPER ALLOY ENCLOSURES - An antifouling barrier comprising a silicon bronze alloy, the silicon bronze alloy comprising about 0.5% to about 3.8% silicon (wt/wt alloy) and greater than about 90% copper (wt/wt alloy). In some embodiments, the silicon bronze alloy additionally comprises from about 0.05% to about 1.3% manganese (wt/wt alloy). The antifouling barrier may be a welded wire mesh, screen, chain-link, chain-mail, grid, weave, perforated sheet, or chicken wire. Methods of reducing the growth of an organism on an animal enclosure, comprising contacting at least a portion of the animal enclosure with an antifouling barrier comprising a silicon bronze alloy comprising about 0.5% to about 3.8% silicon (wt/wt alloy) and greater than about 90% copper (wt/wt alloy). | 05-26-2011 |
20110183008 | Lactoferrin - A pure lactoferrin polypeptide containing no more than two metal ions per molecule, or a mixture of the polypeptide and a fragment thereof. The polypeptide or the mixture stimulates skeletal growth and inhibits bone resorption. Also disclosed is a method of treating a bone-related disorder with the polypeptide or the mixture. | 07-28-2011 |
20110195132 | Self-Preserved Aqueous Pharmaceutical Compositions - The present invention is directed to the provision of multi-dose, self-preserved ophthalmic compositions. The compositions possess sufficient antimicrobial activity to satisfy USP preservative efficacy requirements, as well as similar preservative standards (e.g., EP and JP), without requiring the presence of conventional anti-microbial preservative agents, such as benzalkonium chloride. The compositions are effectively preserved by a balanced ionic buffer system containing zinc ions at a concentration of 0.04 to 0.9 mM, preferably 0.04 to 0.4 mM. One aspect of the balanced buffer system is limitation of the amount of buffering anions present to a concentration of 15 mM or less, preferably 5 mM or less. In a preferred embodiment, the compositions also contain borate or, most preferably, one or more borate/polyol complexes. The use of propylene glycol as the polyol in such complexes is strongly preferred. Limiting the amount of divalent metals other than zinc and the amount of ionized salts present has also been determined to be important to maximize the antimicrobial activity of the balanced buffer systems. | 08-11-2011 |
20110206777 | INORGANIC OXIDE NANO MATERIALS AS ANTI-MICROBIAL AGENTS - An anti-microbial composition includes a doped zinc oxide of formula Zn | 08-25-2011 |
20110212188 | PREVENTING AND/OR TREATING CARDIOVASCULAR DISEASE AND/OR ASSOCIATED HEART FAILURE - Methods are provided for reducing copper values for, by way of example, treating, preventing or ameliorating tissue damage such as, for example, tissue damage that may be caused by (i) disorders of the heart muscle (for example, cardiomyopathy or myocarditis) such as idiopathic cardiomyopathy, metabolic cardiomyopathy which includes diabetic cardiomyopathy, alcoholic cardiomyopathy, drug-induced cardiomyopathy, ischemic cardiomyopathy, and hypertensive cardiomyopathy, (ii) atheromatous disorders of the major blood vessels (macrovascular disease) such as the aorta, the coronary arteries, the carotid arteries, the cerebrovascular arteries, the renal arteries, the iliac arteries, the femoral arteries, and the popliteal arteries, (iii) toxic, drug-induced, and metabolic (including hypertensive and/or diabetic disorders of small blood vessels (microvascular disease) such as the retinal arterioles, the glomerular arterioles, the vasa nervorum, cardiac arterioles, and associated capillary beds of the eye, the kidney, the heart, and the central and peripheral nervous systems, (iv) plaque rupture of atheromatous lesions of major blood vessels such as the aorta, the coronary arteries, the carotid arteries, the cerebrovascular arteries, the renal arteries, the iliac arteries, the fermoral arteries and the popliteal arteries, (v) diabetes or the complications of diabetes. | 09-01-2011 |
20110223259 | ANTI-VIRAL PHARMACEUTICAL COMPOSITIONS - The present invention provides antiviral compositions that comprise one or more of an ionic multivalent metal component, a cationic polymer, and a cationic surfactant. The present invention also provides methods for making and using such antiviral compositions. | 09-15-2011 |
20110236505 | CARBOHYDRATE BAR - The present invention generally relates to the field of nutrition, in particular performance nutrition. In particular, the present invention relates to a novel carbohydrate bar comprising glucose and fructose in a ratio in the range of 3:1 to 1:1. The carbohydrate bar of the present invention can be used to treat or prevent problems with the gastrointestinal tract while allowing for an enhanced blood sugar maintenance and/or an increased exogenous carbohydrate oxidation. | 09-29-2011 |
20110256239 | INGESTIBLE HAIR AND FINGER NAIL GROWTH PROMOTER AND METHOD - A composition and method for promoting hair growth comprising oral administration of a whey protein based formulation containing particular percentages of vitamins and supplements from between 2 weeks to 6 months. | 10-20-2011 |
20110274769 | Antibacterial Melamine Product - An antibacterial melamine product includes a main body that is formed by heating and filling molding to have a predetermined shape. The main body includes a substrate portion and an antibacterial agent mixed with the substrate portion. The substrate portion is made of melamine formaldehyde. The antibacterial agent is fused in the substrate portion evenly. Thus, the antibacterial agent is mixed with the substrate portion to form the main body so that the main body of the antibacterial melamine product has different antibacterial effects by the antibacterial features provided by the antibacterial agent. | 11-10-2011 |
20110280960 | THICK PINE NEEDLE EXTRACT COMPOSITION FOR CAPSULATION - The invention relates to pharmaceutics and to the pharmaceutical and food industries, in particular, to the production of compositions for stimulating the mucous membrane, ameliorating skin integument, and enhancing the organism's immunity. The aim of the invention is to develop a compound containing a thick pine needle extract with an improved quality composition in order to increase the biological activity of components and to preserve the processing characteristics and stability of the thick pine needle extract composition in capsular form. The aim is achieved by adding α-tocopherol (vitamin E), retinol (vitamin A), naphthoquinones (vitamin K), essential fatty acids (vitamin F) and microelements (zinc, selenium), with a specified component ratio, into the thick pine needle extract composition for capsulation. | 11-17-2011 |
20110280961 | Synergistic antimicrobial mixtures - A broad spectrum antimicrobial composition consisting essentially of an iodopropynyl compound in combination with a benzimidazole and a metal borate is disclosed. The composition can be used to protect industrial systems against microbial growth and, more particularly, to protect substrates such as paints, coatings, stucco, concrete, stone, cementaceous surfaces, wood, wood-plastic composites, caulking, sealants, textiles, leather, wood, preservatives, metal working fluids, drilling muds, clay slurries, glazes, optical brighteners, carpet backing, and pigments against microbial growth. The composition can be used as a preservative for aqueous products. | 11-17-2011 |
20120040018 | Ingestible Supplement for Women - An ingestible nutritional substance (supplement and the like) including vitamins, minerals and other ingredients beneficial to a woman and/or her child that a woman may take at a time of her life surrounding pregnancy. This includes by ingesting determined and suited types and amounts of ingredients, including at selected times, to best assist the woman and/or infant's needs at the respective times. The ingestible supplement can be formulated for drinking with appropriate nutritional and health benefits as well as with desired lifestyle and taste and aesthetic attributes. The dosing and packaging of the supplement to best suit a specific class of woman's and baby's needs are also described. Other aspects are directed to the preservation, storage and dispensation of one or more ingredients that may not be stable with one another during storage. | 02-16-2012 |
20120064174 | METHOD FOR STIMULATING HAIR GROWTH - The present teachings provide methods for stimulating the hair growth on a human head including simultaneous administration:
| 03-15-2012 |
20120121726 | KITS AND METHODS FOR NUTRITION SUPPLEMENTATION - The present invention relates to methods of co-administration of various vitamin and mineral compositions, and in a specific embodiment, said methods comprise co-administering one composition comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D | 05-17-2012 |
20120183627 | COMPOSITIONS FOR THE TREATMENT OF HEMORRHOIDS AND RELATED DISEASES - The present invention relates to pharmaceutical, nutraceutical, health foods and medical device compositions comprising polysaccharides from | 07-19-2012 |
20130045283 | COMPOSITIONS FOR AND METHODS OF CONTROLLING OLFACTORY RESPONSES TO ODORANTS - A composition, system and method for modifying an olfactory response to an odorant is disclosed. In some embodiments, the composition includes crystalline metal nanoparticles dispersed in an aqueous medium. The composition is applied to olfactory tissues using a suitable applicator or dispenser. The metal nanoparticles are believed to interact with a G-protein coupled to receptor located in the cilia to moderate (enhance or reduce) sensitivity or ability to smell particular odorants. In accordance with an embodiment of the invention, the composition includes one or more odorants. | 02-21-2013 |
20130071490 | X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT, REDUCE OR DELAY THE ONSET OF CNS INFLAMMATION AND INFLAMMATION ASSOCIATED CONDITIONS - Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers. | 03-21-2013 |
20130101678 | Compositions and Methods for Treating Vaginal Infections and Pathogenic Vaginal Biofilms - The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections. | 04-25-2013 |
20130136803 | COMPOSITIONS FOR ALGAE TREATMENT IN RECIRCULATING AND STAGNANT WATER SYSTEMS - The present invention provides a composition for treating recirculating or stagnant water. The composition contains a phosphorus-containing compound, which is metaphosphate compound, a polyphosphoric acid or a polyphosphate, and one or more zinc compounds. The phosphorus-containing compound is a compound which is not readily hydrolyzable to an orthophosphate. | 05-30-2013 |
20130243885 | Decontamination solution and its use for denaturation, modification, degradation, solubilisation and removal of proteins, nucleic acid molecules and microorganisms - The invention concerns a three component system comprising surface-active substances, vitamins and metal ions for efficient destruction and removal of contaminating proteins, nucleic acids and microorganisms from surfaces like for example laboratory benches, floors, equipment and instruments. These non-corrosive and non-toxic solutions for removal of proteins, nucleic acids and microorganisms are applied by spraying, rubbing or immersion of contaminated surfaces thereby destroying, solubilizing inactivating and removing proteins and nucleic acids. In that way also microorganisms are killed with high efficiency and at the same time all genetic information is inactivated. | 09-19-2013 |
20130273176 | METHODS AND COMPOSITIONS USEFUL FOR PROMOTING SLEEP IN ANIMALS - Methods and compositions for promoting sleep in an animal are provided. In a general aspect, a sleep promoting amount of astaxanthin and a sleep promoting amount of melatonin are administered in conjunction to an animal. The astaxanthin can be administered in an amount ranging from about 0.1 to about 60 mg/kg/body weight of the animal. The melatonin can be administered in an amount ranging from about U. I to about 40 mg/kg/body weight of the animal. The method can further comprise administering in conjunction a sleep promoting amount of zinc to the animal. The zinc can be administered in an amount ranging from about 10 to about 100 mg/kg/body weight of the animal. | 10-17-2013 |
20130287863 | ISOTHIAZOLINONE BIOCIDES ENHANCED BY ZINC IONS - The present invention relates to an antimicrobial composition comprising an isothiazolinone, such as 1,2-benzisothiazolin-3-one, and a zinc compound selected from zinc salts, zinc oxides, zinc hydroxides or combinations thereof. Useful zinc salts include for example, oxides, sulfates, chlorides, and combinations thereof. In use, the zinc from the zinc compound enhances the antimicrobial activity to the isothiazolin-containing composition. This enhancement permits achieving the desired antimicrobial activity at a lower usage rate than is achieved using the isothiazolinone in the absence of the zinc compound. The antimicrobial composition can also contain co-biocides, such as pyrithiones, including zinc pyrithione or copper pyrithione. | 10-31-2013 |
20130309320 | COMBINATIONS OF 4-BROMO-2-(4-CHLOROPHENYL)-5-TRIFLUOROMETHYL)-1H-PYRROLE-3-CARBONITRILE AND METAL COMPOUNDS - The present invention relates to combinations of 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, or a salt thereof, and copper or zinc compounds which provide an improved protecting effect against fouling organisms. More particularly, the present invention relates to compositions comprising a combination of 4-bromo-2-(4-chlorophenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, or a salt thereof, together with one or more copper or zinc compounds selected from Cu | 11-21-2013 |
20130337086 | MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE - The present disclosure generally relates to the medical use of compositions comprising a mineral salt and a sulfonic acid for prevention and/or treatment of one or more mucosal diseases, disorders, or conditions or one or more dermal diseases, disorders, or conditions. | 12-19-2013 |
20140056994 | Fixed-Dose Association of Phytate and Zinc - The invention relates to a fixed-dose association of phytate and zinc in synergic proportions for use in the treatment of crystallization of hydroxyapatite. Advantageously, said association is in a molar ratio between the phytate and the zinc exceeding 4:1. The invention also relates to the use of said association for manufacturing a drug for the treatment, prophylaxis and/or prevention crystallization of hydroxyapatite in humans. | 02-27-2014 |
20140079810 | X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME - Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers. | 03-20-2014 |
20140079811 | X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT, REDUCE OR DELAY THE ONSET OF CNS INFLAMMATION AND INFLAMMATION ASSOCIATED CONDITIONS - Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers. | 03-20-2014 |
20140113004 | Compositions and Methods for the Prevention of Esophageal Cancer - Methods of inhibiting Barrett's esophagus and/or adenocarcinoma in a subject are provided. In a particular embodiment, the method comprises administering at least one composition comprising at least one zinc compound and at least one pharmaceutically acceptable carrier to the esophagus of the subject. The zinc may be a pharmaceutically acceptable salt of zinc, such as zinc gluconate. The zinc may be administered, for example, orally, topically, or by an implantable medical device. In a particular embodiment, the methods further comprise administering at least one analgesic, anesthetic, or other therapeutic agent or therapy for the treatment of Barrett's esophagus. The method may further comprise monitoring the progression of Barrett's esophagus in the subject. | 04-24-2014 |
20140134272 | METHODS OF ENHANCING WOUND HEALING - The present invention relates to ionic compositions for enhancing wound healing, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride. Methods of enhancing wound healing, enhancing sinonasal mucosal healing, promoting mucosal reciliation, and debriding tissue by administering the compositions of the present invention are also presented. | 05-15-2014 |
20140134273 | METHODS OF ENHANCING WOUND HEALING USING MAGNESIUM AND BROMIDE - The present invention relates to ionic compositions for enhancing wound healing, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride. Methods of enhancing wound healing, enhancing sinonasal mucosal healing, promoting mucosal reciliation, and debriding tissue by administering the compositions of the present invention are also presented. | 05-15-2014 |
20140147514 | EXTRACTION OF VITAMINS AND MINERALS FROM PLANT MATTER - A process for extracting vitamins and minerals from a first plant matter(s) is disclosed wherein the said first plant matter(s) is treated with acidic matter followed by extraction with water. Said treatment converts the water-insoluble vitamins and minerals into water-soluble forms leading to a more comprehensive extraction with better yields of the plant constituents. Suitable selection of the first and second plant matter(s) and their proportions yields an extract that is a ready-made formulation of the desired vitamins and minerals in RDA quantities. Other advantages are reduced processing times and processing steps. Extraction of guava fruits, guava leaves, holy basil leaves, lemon peels, amla fruits, annato seeds, Wrightia tinctoria, Lantana camara, bamboo shoots, mustard seeds, and curry leaves is described. | 05-29-2014 |
20140161906 | USE OF ANGIOGENESIS ANTAGONISTS IN CONDITIONS OF ABNORMAL VENOUS PROLIFERATION - The present application describes therapy with angiogenesis antagonists such as anti-VEGF antibodies. In particular, the application describes the use of such angiogenesis antagonists to treat end-stage liver disease and end-stage liver disease complications. The present application also describes the use of such angiogenesis antagonists to treat disorders of altered venous proliferation such hemorrhoids and varicose veins. | 06-12-2014 |
20140220155 | VAGINAL TISSUE REJUVENATION COMPOSITIONS AND METHODS - A method of stimulating elastin and/or collagen production in the tissues of the vagina, comprising the steps of providing a composition including at least one of a water soluble zinc salt such as zinc sulfate and a peroxisome proliferator-activated receptor beta/delta (PPAR 13/8) agonist, and administering the composition to the tissue of the vagina. Compositions for stimulating 5 elastin and/or collagen production in the tissues of the vagina are also disclosed. | 08-07-2014 |
20140220156 | METHOD OF PROMOTING MUCOSAL RECILIATION - The present invention relates to ionic compositions for promoting mucosal reciliation, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride. | 08-07-2014 |
20140220157 | METHOD OF DEBRIDING TISSUE - The present invention relates to ionic compositions for debriding a tissue, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride. | 08-07-2014 |
20140242191 | Prevention of Starch Degradation in Pulp, Paper or Board Making Processes - The invention relates to biocidal systems comprising zinc ions and an oxidizing or non-oxidizing biocide, their use, and methods for preventing or decreasing starch degradation in starch-containing process waters from pulp, paper or board production processes. | 08-28-2014 |
20140255511 | ACCELERATING MUSCLE RECOVERY AFTER IMMOBILIZATION-INDUCED MUSCLE ATROPHY - The present invention generally relates to the field of medical nutrition. For example, the present invention provides a composition that can be used to treat, prevent and/or reverse muscle atrophy related to immobilization and its consequences. One embodiment of the present invention concerns a composition comprising a leucine and antioxidants that can be used in accelerating muscle recovery after muscle atrophy. | 09-11-2014 |
20140271920 | SKIN OINTMENT FORMULATION - An ointment formulation for treating a skin of a mammal includes an occlusive and nourishing ingredient in an amount configured to reduce moisture evaporation from and seal the skin, and supply amino acids to the skin. The formulation also includes an anti-pruritic ingredient in an amount configured to reduce itching of the skin. Additionally, the formulation includes an antiseptic and anti-oxidant providing ingredient in an amount configured to protect the skin against infection. Furthermore, the formulation includes a moisturizing ingredient in an amount configured to soothe and reduce dryness of the skin. A method of generating an ointment formulation to treat a skin disorder is also disclosed. | 09-18-2014 |
20140294990 | THROAT GARGLE TABLET AND METHOD OF USE THEREOF - An anhydrous composition is provided. The anhydrous composition may be a tablet configured to dissolve in water, the tablet including Vitamin C (as ascorbic acid), Vitamin E (as dl-alpha-tocopheryl acetate), Magnesium (as magnesium sulfate and magnesium oxide), Zinc (as zinc sulfate), Chloride (as sodium chloride), Sodium (as sodium chloride, sodium bicarbonate and Sodium carbonate), Potassium (as potassium bicarbonate), Salt (as sodium chloride), Aloe Vera, Chamomile (as matricaria recutita), Honey, and/or Stevia Leaf extract. The anhydrous composition may further comprise Citric Acid, Sorbitol, Natural flavor, Wheat Germ Oil, and/or Magnesium Oxide. | 10-02-2014 |
20140294991 | MEDICAMENT FOR TREATING ANTERIOR EYE DISEASE COMPRISING REBAMIPIDE AND A TEAR-RETAINING AGENT - The present invention provides a combination of rebamipide and a tear-retaining agent as a medicament for the treatment of anterior eye diseases. | 10-02-2014 |
20140302170 | COMPOSITIONS AND METHODS FOR PROMOTING SLEEP - Described herein are food formulations and methods, which promote sleep. | 10-09-2014 |
20140302171 | Cysteine Peptide-Containing Health Drink - An object is to provide a health drink which gives a real feeling of a preventive effect and ameliorative effect against skin aging and stress, and it is confirmed that when a drink in which glutathione is added to a conventional drink containing chondroitin, hyaluronic acid, and vitamins is taken, a concentration of blood DHEA-S, which is considered to be an indicator of rejuvenation, is significantly elevated, promoting gene expressions of olfactory receptors and the like, and remarkably ameliorating skin condition, total mood disturbance, autonomic nerve balance, and overall health condition. | 10-09-2014 |
20140314876 | PROTEOMICS BASED DIAGNOSTIC DETECTION METHOD FOR CHRONIC SINUSITIS - The invention provides for a proteomic approach for identification of specific bacterial protein profiles that may be used in the development of methods for the diagnosis of bacterial chronic sinusitis. The invention provides for methods for determining the presence of pathogenic bacteria in the upper respiratory tract of a subject using protein profiles of the pathogenic bacteria. The invention also provides for methods of diagnosing a bacterial infection of the upper respiratory tract of a subject using protein profiles of a pathogenic bacteria. In addition, the invention provides for devices, immunoassays and kits for identifying pathogenic bacteria in the upper respiratory tract. | 10-23-2014 |
20140314877 | INTRA-MAMMARY TEAT SEALANT FORMULATION AND METHOD OF USING SAME TO REDUCE OR ELIMINATE VISUAL DEFECTS IN AGED CHEESES - Described is an intra-mammary teat sealant and a corresponding method of forming a physical barrier in the teat canal of a non-human animal for prophylactic treatment of mammary disorders during the animal's dry period. The method includes the step of infusing a bismuth-free teat seal formulation into the teat canal of the animal. The method also prevents the formation of black spot defect in dairy products, especially cheddar cheese, made from the milk of animals so treated. | 10-23-2014 |
20140328943 | INSULIN COMPOSITIONS AND METHOD OF MAKING A COMPOSITION - The invention is related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. The insulin is an acylated insulin and may be mixed with a further insulin analogue such as the rapid acting insulin Asp B28 human insulin. | 11-06-2014 |
20150064280 | ANTI-ODOUR AND ANTIBACTERIAL FABRIC IN TEXTILE GOODS - This Invention Patent application consists of a fabric to be used in textile applications, which makes those items more comfortable and increases their bactericidal capacity, both in the number of types that it fights, and in the time that this capacity is effective, using a mixture of fibres and performing a series of treatments prior to the final manufacture of the textile goods that reinforce the properties of the fabric. | 03-05-2015 |
20150064281 | OPHTHALMIC COMPOSITION - The present invention provides an ophthalmic composition containing (A) a biguanide-based disinfectant and (B) zinc chloride. According to the present invention, an ophthalmic composition having remarkably increased disinfection effects against | 03-05-2015 |
20150079198 | METHOD AND NUTRITIONAL SUPPLEMENT FOR ENHANCING WEIGHT GAIN OF A MAMMAL - The present invention relates to a method and nutritional supplement which stimulates appetite and slows metabolism of a mammal, thereby enhancing weight gain for the mammal. The method of enhancing weight gain of the mammal comprises administering to the mammal an effective amount of at least two types of alkamide or isobutylamide compound extracted from | 03-19-2015 |
20150125548 | COMBINATION NUTRITIONAL AND NUTRACEUTICAL PRODUCTS - The present invention is directed to nutritional and nutraceutical compositions which comprise novel mixtures of two or more indole-based dietary supplements such as L-tryptophan and melatonin, together with selected minerals and vitamins that stimulate tryptophan metabolism in the direction of serotonin and melatonin, and to their use in a preferred embodiment of the invention in a readily ingested beverage form, optionally combined with a range of other natural ingredients designed to improve the health and state of mind of human subjects. Alternative dosage forms, such as tablets for oral dosing, and dosage forms for buccal and sublingual administration, including thin films, are also incorporated in the present invention. Health improvements include the treatment of disorders of circadian rhythm, such as shift work disorder and jet lag, the induction of relaxation and a restful frame of mind, as well as providing restorative sleep function. The compositions have utility in the treatment of jet lag disorder, circadian rhythm sleep disorders including shift work disorder, and other sleep-related problems. | 05-07-2015 |
20150290158 | X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT, REDUCE OR DELAY THE ONSET OF CNS INFLAMMATION AND INFLAMMATION ASSOCIATED CONDITIONS - Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers. | 10-15-2015 |
20150290243 | Materials and Methods for Prevention and Treatment of Diarrhea and Inflammation in the Gastrointestinal Tract - The present invention pertains to the use of the calcium-sensing receptor (CaSR)-activating nutrients (designated as “CaSR-based nutrients”) for the prevention and/or treatment of diarrheal diseases and inflammation in the gastrointestinal tract. In one embodiment, the current invention is formulated for oral administration. The anti-diarrheal composition of the present invention is useful for treating diarrheal and gastrointestinal inflammatory conditions in infants and young children. | 10-15-2015 |
20150313941 | Composition and methods for amelioration of diseases and related symptoms in domestic animals - The present invention is generally directed to compositions and methods for amelioration of diseases and related symptoms in domestic animals. In one aspect, the invention is directed to a method of ameliorating the symptoms of arthritis, brain aging, cataracts, diabetes, dermatitis, FLUTD, glaucoma, low energy levels or obesity in a domestic animal, wherein the method comprises administering a composition to the animal, wherein the composition comprises a Fruit-Based Additive, a Vegetable-Based Additive or a Fruit- and Vegetable-Based Additive. | 11-05-2015 |
20150328098 | NON-IRRITATING, NON-BLURRING OPHTHALMIC SUNSCREEN - A non-irritation, non-blurring ophthalmic sunscreen composition contains a liquid vehicle base, such as an artificial tear formulation or an ophthalmic suspension or ointment. The composition includes at least one inorganic and/or at least one organic active ingredient. The inorganic active ingredients may include, but not be limited to zinc oxide, titanium dioxide, iron oxide, zirconium oxide, and cerium oxide. The organic active ingredients may include, but not be limited to dioxybenzone, octinoxate, octisalate, homosalate, avobenzone, octocrylene, para-aminobenzoic acid, cinoxate, methyl anthranilate, octocrylene, padimate O, ensulizole, sulisobenzone, trolamine salicylate, and ecamsule. | 11-19-2015 |
20150352149 | METHOD FOR STIMULATING RETINAL RESPONSE USING PHOTOACTIVE DEVICES - An improved method for stimulating electrical activity in an eye is provided. Provided is a technique for implanting small, nanometer-sized photoactive devices into an eye to improve electrical activity within an eye or mitigate degradation of electrical response in damaged eyes. | 12-10-2015 |
20160015762 | Antiviral supplement compositions and methods of use - The present invention relates to the field of dietary supplements, and in particular to antiviral compositions and methods of use. Compositions are described involving various combinations of | 01-21-2016 |
20160081348 | Decontamination solution and its use for denaturation, modification, degradation, solubilisation and removal of proteins, nucleic acid molecules and microorganisms - The invention concerns a three component system comprising surface-active substances, vitamins and metal ions for efficient destruction and removal of contaminating proteins, nucleic acids and microorganisms from surfaces like for example laboratory benches, floors, equipment and instruments. These non-corrosive and non-toxic solutions for removal of proteins, nucleic acids and microorganisms are applied by spraying, rubbing or immersion of contaminated surfaces thereby destroying, solubilizing inactivating and removing proteins and nucleic acids. In that way also microorganisms are killed with high efficiency and at the same time all genetic information is inactivated. | 03-24-2016 |
20160083451 | METHODS AND SYSTEMS FOR ZINC DELIVERY USING INTRINSIC FACTOR OR HAPTOCORRIN - Improved delivery of zinc using haptocorrin or intrinsic factor modified to include a zinc binding sequence that can outcompete dietary zinc inhibitors such as phytin. Known zinc binding sequences can be assayed to determine competitiveness with respect to phytin and, if successful, incorporated into the B | 03-24-2016 |
20160151437 | NUTRITIONAL SUPPLEMENTS FOR IMPROVED VISION AND METHODS OF TREATING THE SAME | 06-02-2016 |
20160374940 | ORAL DELIVERY COMPOSITIONS FOR TREATING DERMATITIS DISORDERS IN MAMMALS - A composition for treating atopic dermatitis in animals containing active compositions of ceramides for skin barrier protection, omega 3 and omega 6 fatty acids for reducing pruritus and botanical extracts for inhibiting 5-lipoxygenease activity, histamine release while modulating the immune system. The active compositions are placed in a soft dough oral delivery system. | 12-29-2016 |
20170231954 | A COMPOSITION FOR THE PREVENTION AND TREATMENT OF METABOLIC DISORDERS ASSOCIATED WITH MENOPAUSE AND CLIMACTERIC | 08-17-2017 |